정신분열병 환자의 혈청에서 Brain-Derived Neurotrophic Factor 증가
Serum Brain-Derived Neurotrophic Factor in Schizophrenia
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Abstract
Abnormalities in neurotrophic factors that regulate neuronal development and synaptic plasticity are often implicated as some causes of schizophrenia. In previous studies, researchers reported that brain and serum BDNF levels underwent similar changes during maturation and aging processes in rats. They also found a positive correlation between serum and cortical BDNF levels. In this study, we investigated whether the serum levels of BDNF in Korean schizophrenic patients would be different from those of healthy controls. Methods：Using an ELISA kit, serum BDNF levels were assessed in schizophrenic group(N=49) and control group(N=50). Results：Serum BDNF levels in the schizophrenic group(36.29±19.78ng/ml) were significantly higher than those in control group(22.4±14.4ng/ml). The BDNF levels did not correlate with duration of treatment, age or daily dose of antipsychotics in patients with schizophrenia. Conclusions：This result suggests that schizophrenia is characterized by high serum BDNF levels and supports the hypothesis of neurotrophic factor involvement in psychotic disorder. Serum BDNF level is likely to be one of the possible biological markers for schizophrenia.
참고문헌 (23)
- "Critical review of recent adoptiontwin and family study of schizophrenia:Behaviorgenetics perspectives.", pp.360~401 (1976)
- "Effects of family history andplace and season of birth on the risk of schizophrenia", 340, pp.603~608 (1999)
- "Perinatal risk factors and schizophrenia:selective review and methodological concerns", 17, pp.107~112 (1995)
- "Schizophrenia after prenatal exposure to 1957 A2 influenzaepidemic", pp.1248~1250
- "Schizophrenia after prenatal famine", 53, pp.25~31 (1996)
- "The association betweenseason of birth and the risk for schizophrenia AmericanJournal of Epidemiology 1981;114", pp.735~749
- "from molecule to man Trends in Neuroscience1994;17"
- "Low nerve growth factor plasma levels inschizophrenic patients.", 37, pp.197~203 (1999)
- "Presence of BDNF in brain andhuman and rat but not mouse serum detected by a sensitiveand specific immunoassay", 709, pp.122~301 (1996)
- "Abnormal expression ofBDNF and its receptor in the corticolimbic system ofschizophrenic patients", 5, pp.293~300 (2000)
- "Brain-derived neurotrophicfactor and neurotrophin-3 in schizophrenic psychoses", 9, pp.79~86 (2000)
- "Postnatal developmentalprofile of brain-derived neurotrophic factor in rat brainand platelets", 328, pp.261~264 (2002)
- "Transport of brain-derived neurotrophic factor acrossthe blood-brain barrier", 37, pp.1553~1561 (1998)
- "Decreased levelsof brain-derived neurotrophic factor in serum of chronicschizophrenic patients", 110, pp.249~257 (2002)
- "Performance of heterozygousbrain-derived neurotrophic factor knockout mice on behavioranalogues of anxiety nociception, and depression", 115(ciception), pp.1145~1153 (2001)
- "Increased hippocampal BDNF immunoreactivityin subjects treated with antidepressant medication", 50, pp.260~265 (2001)
- "Regulation of BDNFand trkB m RNA in rat brain by chronic electroconvulsiveseizure and antidepressant drug treatment", 15, pp.7539~7547 (1995)
- "Neuropeptides and neurotrophinsin neonatal blood of children with autism or mentalretardation", 49, pp.597~606 (2001)
- "BDNF is reduced in Alzheimer’s disease", 49, pp.71~81 (1997)
- "BDNF and neurotrophin-3 levels in Alzheimer’s disease brains", 18, pp.807~813 (2003)
- "Human platelet containbrain-derived neurotrophic factor", 10, pp.3469~3478 (1990)
- "Nerve growthfactor levels in normal human sera", 8, pp.179~181 (1996)
- "Cellular location of the Trkneurotrophin receptor family in human non-neuronal tissues", 148, pp.1807~1818 (1996)